Table 3.
Predictors of hospital admission among T2D patients on follow up in governmental hospitals of Harari regional state of Ethiopia (2013–2017)
| Variables | Categories | Crude HR (95%CI) | Adjusted HR (95%CI) |
|---|---|---|---|
| Age | < 45 | 1 | 1 |
| 45–65 | 0.77 (0.53, 1.12) | 0.78 (0.50, 1.20) | |
| above 65 | 0.94 (0.58, 1.51) | 0.63 (0.37, 1.09) | |
| Sex | Male | 1 | 1 |
| Female | 1.63 (1.42, 1.87) * | 0.71 (0.46, 0.96) * | |
| Resident | Urban | 1 | 1 |
| Rural | 2.71 (1.75, 4.21) ** | 3.57 (2.23, 5.72) ** | |
| BMI | < 25 kg/m2 | 1 | 1 |
| 25–29.9 kg/m2 | 1.86 (0.38, 1.97) | 1.09 (0.46, 2.55) | |
| ≥30 kg/m2 | 0.82 (0.34, 1.13) | 0.92 (0.49, 1.72) | |
| Smoking | No | 1 | 1 |
| Yes | 1.55 (0.76, 3.17) | 0.96 (0.43, 2.19) | |
| Alcohol | No | 1 | 1 |
| Yes | 1.87 (1.05, 3.32) * | 2.29 (1.19, 4.38) * | |
| Life style | active | 1 | 1 |
| Inactive | 1.35 (0.96, 1.89) | 1.88 (1.26, 2.81) ** | |
| Comorbidities | No | 1 | 1 |
| One | 0.84 (0.57, 1.25) | 0.91 (0.61, 1.37) | |
| Two | 1.50 (0.93, 2.41) | 1.40 (0.84, 2.35) | |
| More than two | 3.17 (1.52, 6.65) | 4.46 (1.86, 10.71) ** | |
| Diabetes complication | No | 1 | 1 |
| Yes | 1.35 (0.90, 2.01) | 1.19 (1.06, 1.59) * | |
| Treatment | Metformin only | 1 | 1 |
| Combination a | 0.86 (0.61, 1.21) | 1.04 (0.71, 1.54) | |
| Insulin administered | No | 1 | 1 |
| Yes | 0.87 (0.60, 1.26) | 1.33 (0.81, 2.19) | |
| Blood glucose level | 1.03 (1.01, 1.04) | 1.03 (1.01, 1.04) * | |
| Baseline creatinine | 1.01 (0.69, 1.44) | 0.87 (0.58, 1.30) | |
| 1/gamma | 0.07 (0.05, 0.08) |
BMI body mass index, kg/m2 kilograms per meter square, mg/dl milligram per deciliter, HR Hazard rate, CI confidence interval, *; p-value< 0.05 **; p-value< 0.001
a: taking both metformin and glibenclamide